Joining Cool Science Radio is Dr. Michael Selsted, Chief Science Officer for Oryn Therapeutics. Oryn Therapeutics has products in pre-clinical testing that could have a profound impact on the treatment of autoimmune and inflammatory diseases and life-threatening, drug-resistant infections.
Oryn Therapeutics Treating Autoimmune Disease with 'Orynotides'
Facebook Twitter LinkedIn Email
Your browser doesn’t support HTML5 audio